← Leaderboards
Debra A. Schwinn
Duke University
$11,466,054
Attributed
$11,466,054
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$11,466,054 · 9
By mechanism
R01$6,217,884 · 4
R37$3,921,913 · 1
M01$690,957 · 2
T32$550,974 · 1
K02$84,326 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Walter J Koch$36,219,689
- Robert J Lefkowitz$17,365,480
- Mark Franklin Newman$5,270,323
- Douglas Brock Cines$21,888,352
- Daniel B Mark$29,174,449
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationHuman TissueReceptor ExpressionMyocardiumReceptor SensitivityAdrenergic ReceptorHuman SubjectClinical ResearchHypertensionHuman Therapy EvaluationBlood VesselsBeta Adrenergic ReceptorGenetic Regulatory ElementGel Mobility Shift AssayHeart /Lung BypassPathologic ProcessTranscription FactorAlpha Adrenergic ReceptorProstateCell LineAntiadrenergic AgentsDrug Screening /EvaluationMediatingAgonist
Grant awards (37)
Subcellular Distribution & Regulation of Ala1 Adrenoceptors$387,425
R37 · FY2014 · HL · contact PI
Subcellular Distribution & Regulation of Ala1 Adrenoceptors$329,627
R37 · FY2013 · HL · contact PI
Subcellular Distribution & Regulation of Ala1 Adrenoceptors$430,508
R37 · FY2012 · HL · contact PI
Subcellular Distribution & Regulation of Ala1 Adrenoceptors$428,516
R37 · FY2011 · HL · contact PI
Anesthesiology & Perioperative Medicine Research Training$210,174
T32 · FY2011 · GM · contact PI
Subcellular Distribution & Regulation of Ala1 Adrenoceptors$432,845
R37 · FY2010 · HL · contact PI
Anesthesiology & Perioperative Medicine Research Training$204,796
T32 · FY2010 · GM · contact PI
Subcellular Distribution & Regulation of ala-Adrenocepto$393,495
R37 · FY2009 · HL · contact PI
Anesthesiology & Perioperative Medicine Research Training$136,004
T32 · FY2009 · GM · contact PI
Subcellular Distribution & Regulation of ala-Adrenocepto$393,495
R37 · FY2008 · HL · contact PI
Subcellular Distribution & Regulation of ala-Adrenocepto$365,049
R37 · FY2007 · HL · contact PI
Genetics Myocardial Adverse Outcomes/Graft Failure-CABG$719,029
R01 · FY2006 · HL · contact PI
Subcellular Distribution & Regulation of ala-Adrenocepto$375,953
R37 · FY2006 · HL · contact PI
Genetics Myocardial Adverse Outcomes/Graft Failure-CABG$743,393
R01 · FY2005 · HL
Subcellular Distribution &Regulation of ala-Adrenocepto$385,000
R37 · FY2005 · HL
PHARMACOGENETICS OF CX(1A)-ADRENOCEPTORS IN HYPERTENSION$34,834
M01 · FY2005 · RR
Genetics Myocardial Adverse Outcomes/Graft Failure-CABG$659,929
R01 · FY2004 · HL
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS$408,607
R01 · FY2004 · AG
Pharmacogenetics of a(1a)-Adrenoceptors in Hypertension$9,451
M01 · FY2004 · RR
B-Adrenergic Receptor Antagonists in Cardiac Surgery$2,537
M01 · FY2004 · RR
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS$399,396
R01 · FY2003 · AG
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORS$393,003
R01 · FY2003 · HL
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS$390,449
R01 · FY2002 · AG
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORS$384,305
R01 · FY2002 · HL
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$117,022
M01 · FY2002 · RR
B ADRENOCEPTORS DURING CARDIOPULMONARY BYPASS$411,875
R01 · FY2001 · HL
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS$381,766
R01 · FY2001 · AG
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORS$372,648
R01 · FY2001 · HL
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$293,069
M01 · FY2001 · RR
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$117,022
M01 · FY2001 · RR
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$117,022
M01 · FY2001 · RR
B ADRENOCEPTORS DURING CARDIOPULMONARY BYPASS$361,721
R01 · FY2000 · HL
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS$318,482
R01 · FY2000 · AG
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORS$273,281
R01 · FY2000 · HL
TRANSCRIPTIONAL REGULATION OF THE HUMAN 1A ADRENOCEPTORS$84,326
K02 · FY2000 · AG
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$0
M01 · FY2000 · RR
ROLE OF B ADRENERGIC RECEPTOR ANTAGONISTS IN CARDIAC SURGERY PATIENTS$0
M01 · FY2000 · RR